Townsquare Capital LLC Gilead Sciences, Inc. Transaction History

Townsquare Capital LLC

$8.15 Billion
Q3 2024

A detailed history of Townsquare Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Townsquare Capital LLC holds 134,964 shares of GILD stock, worth $12.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

134,964

Previous 117,968 14.41%

Holding current value

$12.9 Million

Previous $8.09 Million 39.78%

% of portfolio

0.14%

Previous 0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $1.13 Million - $1.43 Million	16,996 Added 14.41%	134,964 $11.3 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $45,657 - $52,692	723 Added 0.62%	117,968 $8.09 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $1.47 Million - $1.79 Million	-20,535 Reduced 14.9%	117,245 $8.59 Million
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $4.55 Million - $5.16 Million	62,052 Added 81.94%	137,780 $11.2 Million
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $465,378 - $507,736	6,294 Added 9.06%	75,728 $5.68 Million
Q2 2023 Nov 13, 2023	BUY	$76.01 - $86.7 $397,380 - $453,267	5,228 Added 8.14%	69,434 $5.35 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $153,151 - $174,486	1,981 Added 3.18%	64,206 $5.33 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $772,144 - $1.11 Million	-12,390 Reduced 16.61%	62,225 $5.34 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $53,109 - $60,664	892 Added 1.21%	74,615 $4.6 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $150,245 - $169,221	2,603 Added 3.66%	73,723 $4.56 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $359,277 - $450,213	6,203 Added 9.56%	71,120 $4.23 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $828,777 - $940,677	-12,774 Reduced 16.44%	64,917 $4.71 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $503,613 - $543,343	7,440 Added 10.59%	77,691 $5.43 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $583,987 - $638,089	9,201 Added 15.07%	70,251 $4.81 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $889,440 - $1.01 Million	14,824 Added 32.07%	61,050 $3.95 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $845,444 - $963,344	14,924 Added 47.68%	46,226 $2.69 Million
Q3 2020 Dec 01, 2020	BUY	$62.1 - $78.08 $149,909 - $188,485	2,414 Added 8.36%	31,302 $1.96 Million
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $1.85 Million - $2.15 Million	25,617 Added 783.15%	28,888 $2.22 Million
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $22,108 - $28,317	-353 Reduced 9.74%	3,271 $262,000
Q4 2019 May 18, 2020	SELL	$61.62 - $67.78 $2,156 - $2,372	-35 Reduced 0.96%	3,624 $235,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $17,565 - $19,389	-281 Reduced 7.13%	3,659 $234,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $728,519 - $816,949	-11,775 Reduced 74.93%	3,940 $256,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $752,798 - $843,331	12,039 Added 327.5%	15,715 $1.02 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $222,545 - $290,404	3,676 New	3,676 $249,000

Others Institutions Holding GILD

# of Institutions

1,953

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Account

Townsquare Capital LLC Gilead Sciences, Inc. Transaction History